Bootstrap Bio and Manhattan Genomics, which were pursuing human embryo editing to prevent serious disease, have shut down.
Andrew Bloomenthal has 20+ years of editorial experience as a financial journalist and as a financial services marketing writer. Eric's career includes extensive work in both public and corporate ...
Daniel Liberto is a journalist with over 10 years of experience working with publications such as the Financial Times, The Independent, and Investors Chronicle. Robert Kelly is managing director of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results